
    
      PROTOCOL OUTLINE: Male patients receive leuprolide subcutaneously every 5 days for up to one
      year and are followed at weeks 4, 6, 8, and 12, then every 2 months.

      Female patients receive leuprolide subcutaneously on days 1, 6, and possibly 11. Patients are
      followed 2 months after the last injection.

      Completion date provided represents the completion date of the grant per OOPD records
    
  